We are live on ! Find out more
RJA

Raymond James & Associates Portfolio holdings

AUM $164B
1-Year Est. Return 33.91%
This Fund
S&P 500
This Quarter Est. Return
+7.15%
1 Year Est. Return
+33.91%
3 Year Est. Return
+39.99%
5 Year Est. Return
+107.66%
10 Year Est. Return
+221.81%
AUM
$164B
AUM Growth
+$11.8B
Cap. Flow
+$2.23B
Cap. Flow %
1.36%
Top 10 Hldgs %
25.88%
Holding
4,146
New
203
Increased
1,918
Reduced
1,677
Closed
157

Sector Composition

Rank Sector Weight
1 Technology 16.27%
2 Financials 8.92%
3 Healthcare 7.98%
4 Industrials 6.57%
5 Consumer Discretionary 6.12%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
NMTC icon
4001
NeuroOne Medical Technologies
NMTC
$14.4M
-2,900
Closed -$13.9K
NTB icon
4002
Bank of N.T. Butterfield & Son
NTB
$2.37B
-15,044
Closed -$528K
NVO
4003
PUT
Novo Nordisk
NVO
$225B
-16,600
Closed -$2.08M
NWS icon
4004
News Corp Class B
NWS
$17.2B
-13,156
Closed -$374K
OMFS icon
4005
Invesco Russell 2000 Dynamic Multifactor ETF
OMFS
$283M
-6,582
Closed -$239K
OXM icon
4006
Oxford Industries
OXM
$613M
-2,514
Closed -$252K
PARAA
4007
DELISTED
Paramount Global Class A
PARAA
-10,412
Closed -$191K
PAY icon
4008
Paymentus
PAY
$4.3B
-13,281
Closed -$252K
PECO icon
4009
Phillips Edison & Co
PECO
$5.37B
-24,092
Closed -$788K
PERI icon
4010
Perion Network
PERI
$378M
-81,336
Closed -$679K
PLL
4011
DELISTED
Piedmont Lithium
PLL
-147,522
Closed -$1.47M
PPBT
4012
Purple Biotech
PPBT
$1.28M
-50
Closed -$4.07K
PPI
4013
AXS Astoria Inflation Sensitive ETF
PPI
$155M
-12,475
Closed -$186K
PPH icon
4014
CALL
VanEck Pharmaceutical ETF
PPH
$986M
-200
Closed -$16.4K
PRO
4015
DELISTED
PROS Holdings
PRO
-138,159
Closed -$3.96M
PVI icon
4016
Invesco Floating Rate Municipal Income ETF
PVI
$32.2M
-27,605
Closed -$684K
PXJ icon
4017
Invesco Oil & Gas Services ETF
PXJ
$63.3M
-83,809
Closed -$2.68M
RDFN
4018
DELISTED
Redfin
RDFN
-10,262
Closed -$61.7K
RGR icon
4019
Sturm, Ruger & Co
RGR
$613M
-11,929
Closed -$497K
RXRX icon
4020
Recursion Pharmaceuticals
RXRX
$1.61B
-74,905
Closed -$562K
RXST icon
4021
RxSight
RXST
$251M
-58,988
Closed -$3.55M
SAM icon
4022
Boston Beer
SAM
$1.93B
-800
Closed -$244K
SCYX icon
4023
SCYNEXIS
SCYX
$36.2M
-2,174
Closed -$34.8K
SGMO
4024
DELISTED
SANGAMO THERAPEUTICS INC
SGMO
-13,250
Closed -$4.75K
SHAG icon
4025
WisdomTree Yield Enhanced US Short-Term Aggregate Bond Fund
SHAG
$47.2M
-42,591
Closed -$2M

Similar funds

Raymond James & Associates's Q3 2024 Portfolio in Review

As of Q3 2024, Raymond James & Associates held 4,146 positions worth $164B, up 7.7% from $152B the previous quarter. Its ten largest holdings account for 26% of the portfolio.

Raymond James & Associates's Q3 2024 filing shows 203 new, 1,918 increased, 1,677 reduced and 157 closed positions. Its largest new stake was AllianzIM U.S. Equity Buffer20 Aug ETF: 724,171 shares worth $20.9M. The largest sale was iShares MSCI USA Min Vol Factor ETF, an estimated $516M.

By sector, the portfolio is most concentrated in Technology at 16% of assets, down from 17% a quarter earlier, followed by Financials and Healthcare.

  • Raymond James & Associates's largest Q3 2024 buy was AllianzIM U.S. Equity Buffer20 Aug ETF: 724,171 shares worth $20.9M.
  • Raymond James & Associates added most to iShares Core S&P Mid-Cap ETF in Q3 2024, an estimated $520M increase.
  • Raymond James & Associates's biggest Q3 2024 reduction was iShares MSCI USA Min Vol Factor ETF, cutting an estimated $516M.
  • Raymond James & Associates fully exited Ferguson in Q3 2024, selling an estimated $63.3M.
  • Raymond James & Associates's ten largest holdings make up 26% of its $164B portfolio in Q3 2024.
  • Raymond James & Associates opened 203 new positions and closed 157 in Q3 2024.
  • Raymond James & Associates's portfolio value rose 7.7% quarter-over-quarter to $164B.

Based on Raymond James & Associates's 13F filing for Q3 2024, filed 18 Oct 2024.